BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32907888)

  • 21. COVID-19 and Hypercoagulability.
    Sholzberg M
    Clin Adv Hematol Oncol; 2020 Jul; 18(7):386-389. PubMed ID: 32903249
    [No Abstract]   [Full Text] [Related]  

  • 22. TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction?
    Honore PM; Barreto Gutierrez L; Kugener L; Redant S; Attou R; Gallerani A; De Bels D
    Crit Care; 2020 Oct; 24(1):599. PubMed ID: 33023627
    [No Abstract]   [Full Text] [Related]  

  • 23. Coronavirus blood-clot mystery intensifies.
    Willyard C
    Nature; 2020 May; 581(7808):250. PubMed ID: 32393875
    [No Abstract]   [Full Text] [Related]  

  • 24. The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties.
    Gris JC; Loubet P; Roger C; Cochery-Nouvellon E; Mauboussin JM; Muller L; Bouvier S; Laureillard D; Barbar SD; Mercier É; Lefrant JY; Sotto A
    J Thromb Haemost; 2020 Aug; 18(8):2068-2070. PubMed ID: 32495985
    [No Abstract]   [Full Text] [Related]  

  • 25. COVID-19 and SIC (!).
    Nevzorov I; Tulamo R; Albäck A; Lassila R
    J Vasc Surg; 2020 Sep; 72(3):1148-1150. PubMed ID: 32497749
    [No Abstract]   [Full Text] [Related]  

  • 26. Uncertainties on the prognostic value of D-dimers in COVID-19 patients.
    Gris JC; Quéré I; Pérez-Martin A; Lefrant JY; Sotto A
    J Thromb Haemost; 2020 Aug; 18(8):2066-2067. PubMed ID: 32344457
    [No Abstract]   [Full Text] [Related]  

  • 27. D-dimer Triage for COVID-19.
    Li C; Hu B; Zhang Z; Qin W; Zhu Z; Zhai Z; Davidson BL; Wang C
    Acad Emerg Med; 2020 Jul; 27(7):612-613. PubMed ID: 32506683
    [No Abstract]   [Full Text] [Related]  

  • 28. Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?
    Dorgalaleh A; Dabbagh A; Tabibian S; Baghaeipour MR; Jazebi M; Bahraini M; Fazeli S; Rad F; Baghaeipour N
    Semin Thromb Hemost; 2020 Oct; 46(7):853-855. PubMed ID: 32557449
    [No Abstract]   [Full Text] [Related]  

  • 29. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.
    von Weyhern CH; Kaufmann I; Neff F; Kremer M
    Lancet; 2020 Jun; 395(10241):e109. PubMed ID: 32505222
    [No Abstract]   [Full Text] [Related]  

  • 30. Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients With Severe COVID-19 in Wuhan.
    Ren B; Yan F; Deng Z; Zhang S; Xiao L; Wu M; Cai L
    Circulation; 2020 Jul; 142(2):181-183. PubMed ID: 32412320
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.
    Ramacciotti E; Macedo AS; Biagioni RB; Caffaro RA; Lopes RD; Guerra JC; Orsi FA; Marques MA; Tafur AJ; Caprini JA; Nicolaides A; Carter CA; Filho CC; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936350. PubMed ID: 32649232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoalbuminemia and elevated D-dimer in COVID-19 patients: a call for result harmonization.
    Aloisio E; Serafini L; Chibireva M; Dolci A; Panteghini M
    Clin Chem Lab Med; 2020 Oct; 58(11):e255-e256. PubMed ID: 32692697
    [No Abstract]   [Full Text] [Related]  

  • 33. Re The source of elevated plasma D-dimer levels in COVID-19 infection.
    Hunt BJ; Levi M
    Br J Haematol; 2020 Aug; 190(3):e133-e134. PubMed ID: 32484901
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).
    Marietta M; Ageno W; Artoni A; De Candia E; Gresele P; Marchetti M; Marcucci R; Tripodi A
    Blood Transfus; 2020 May; 18(3):167-169. PubMed ID: 32281926
    [No Abstract]   [Full Text] [Related]  

  • 35. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis.
    Lippi G; Favaloro EJ
    Thromb Haemost; 2020 May; 120(5):876-878. PubMed ID: 32246450
    [No Abstract]   [Full Text] [Related]  

  • 37. Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients.
    Mouhat B; Besutti M; Bouiller K; Grillet F; Monnin C; Ecarnot F; Behr J; Capellier G; Soumagne T; Pili-Floury S; Besch G; Mourey G; Lepiller Q; Chirouze C; Schiele F; Chopard R; Meneveau N
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32907890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focus on coronavirus disease 2019 associated coagulopathy.
    Yang XH; Li RR; Sun RH; Liu J; Chen DC
    Chin Med J (Engl); 2020 Sep; 133(18):2239-2241. PubMed ID: 32858589
    [No Abstract]   [Full Text] [Related]  

  • 39. d-Dimer and COVID-19.
    Oudkerk M; Büller HR; Kuijpers D; Oudkerk SF; van Beek EJR
    Radiology; 2020 Dec; 297(3):E343-E344. PubMed ID: 33048037
    [No Abstract]   [Full Text] [Related]  

  • 40. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.